ETRACS 2x Leveraged MSCI US Quality Factor TR ETN
QULL
0 hedge funds and large institutions have $0 invested in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0.03% less ownership
Funds ownership: 0.03% → 0% (-0.03%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $4.75K → $0 (-$4.75K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$4.75K | -97 | Closed |
|
QULL Hedge Fund Activity: Q3 2025 in Review
0 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) for Q3 2025, worth a combined $0 — down 100% from $4.75K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of QULL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $4.75K sold.
- 0 institutional investors held ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) as of Q3 2025, down from 1 in Q2 2025.
- Funds reported $0 of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged MSCI US Quality Factor TR ETN positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest ETRACS 2x Leveraged MSCI US Quality Factor TR ETN seller in Q3 2025 was UBS Group, an estimated $4.75K sold.
Based on aggregated 13F filings for Q3 2025.